Lunaphore

About:

Lunaphore is a life sciences company that is creating technologies to enable spatial biology in all laboratories.

Website: http://www.lunaphore.com

Twitter/X: lunaphore

Top Investors: Venture Kick, PHC Holdings, VentureOut, Zürcher Kantonal Bank, redalpine

Description:

Lunaphore offers solutions based on a chip technology that can extract spatial proteomic and transcriptome data from tumors and other tissues, transforming any assay into multiplex spatial biology with an easy-to-use interface. Lunaphore enables immunology, immuno-oncology, and neurology researchers to push the boundaries of scientific discovery and therapeutic development. Lunaphore's technology identifies clinically relevant biomarker "signatures" to aid in the development of diagnostic tools and to streamline clinical trials, ultimately improving patient outcomes.

Total Funding Amount:

$94.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lausanne, Vaud, Switzerland

Founded Date:

2014-01-01

Contact Email:

communications(AT)lunaphore.com

Founders:

Ata Tuna Ciftlik, Diego Gabriel Dupouy, Déborah Heintze

Number of Employees:

11-50

Last Funding Date:

2023-03-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai